Diagnosis of Aspergillus niger Peritonitis in a Peritoneal Dialysis Patient by Peritoneal Galactomannan and β–d-Glucan Detection

1. Howard CS, Teitelbaum I. Renal replacement therapy in patients with chronic liver disease. Semin Dial 2005; 18:212–16. 2. Arbeiter AK, Kranz B, Wingen AM, Bonzel KE, Dohna– Schwake C, Hanssler L, et al. Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism. Nephrol Dial Transplant 2010; 25:1257–65. 3. Batshaw ML, Brusilow SW. Treatment of hyperammonemic coma caused by inborn errors of urea synthesis. J Pediatr 1980; 97:893–900. 4. Selgas R, Bajo MA, Del Peso G, Sánchez–Villanueva R, Gonzalez E, Romero S, et al. Peritoneal dialysis in the comprehensive management of end-stage renal disease patients with liver cirrhosis and ascites: practical aspects and review of the literature. Perit Dial Int 2008; 28:118–22. 5. Afsar B, Elsurer R, Bilgic A, Sezer S, Ozdemir F. Regular lactulose use is associated with lower peritonitis rates: an observational study. Perit Dial Int 2010; 30:243–6. 6. Chaudhary K, Khanna R. Renal replacement therapy in end-stage renal disease patients with chronic liver disease and ascites: role of peritoneal dialysis. Perit Dial Int 2008;28:113–17. 7. Morgan AG, Terry SI. Impaired peritoneal fluid drainage in nephrogenic ascites. clin Nephrol 1981; 15:61–5. 8. Tarao K, So K, Moroi T, Ikeuchi T, Suyama T. Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance. Gastroenterology 1977; 73:539–42. doi:10.3747/pdi.2011.00271 Diagnosis of Aspergillus niger Peritonitis in a Peritoneal Dialysis Patient by Peritoneal Galactomannan and β-d-Glucan Detection